News

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. We identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture of the latest advancements spanning diverse therapeutic areas and key development phases.
World’s First Recombinant Anthrax Vaccine Developed in Korea
Vaccines

World’s First Recombinant Anthrax Vaccine Developed in Korea

Akeso’s First Bispecific ADC Enters the Clinic
Proteins, Antibodies & ADCs

Akeso’s First Bispecific ADC Enters the Clinic

‘Anti-Aging Vaccine’ Shows Promising Results in Mice
Vaccines

‘Anti-Aging Vaccine’ Shows Promising Results in Mice

Invivyd’s New mAb for COVID Ticks Safety and PK in Phase I/II

Invivyd’s New mAb for COVID Ticks Safety and PK in Phase I/II

Idorsia Targets Bacteria with New Synthetic Glycan Vaccine Platform
Vaccines

Idorsia Targets Bacteria with New Synthetic Glycan Vaccine Platform

Sangamo to Seek Approval for Fabry Disease Gene Therapy After Phase I/II Results
Cell & Gene

Sangamo to Seek Approval for Fabry Disease Gene Therapy After Phase I/II Results

Paper Suggests Vaccine Type and Patient Sex Linked to COVID T-cell Response
Vaccines

Paper Suggests Vaccine Type and Patient Sex Linked to COVID T-cell Response

Could an In Vivo CAR T Approach be Applied to Autoimmune Diseases? AbbVie Buys Capstan Tx
Cell & Gene

Could an In Vivo CAR T Approach be Applied to Autoimmune Diseases? AbbVie Buys Capstan Tx

Designing the Future: AI Meets Antibody Engineering
Proteins, Antibodies & ADCs

Designing the Future: AI Meets Antibody Engineering

Lung-Targeted Delivery System for Gene Therapies Treats Cancer and Cystic Fibrosis
Cell & Gene

Lung-Targeted Delivery System for Gene Therapies Treats Cancer and Cystic Fibrosis

UCB Plans $5 Billion Manufacturing Investment to Boost Biologics Capacity
Proteins, Antibodies & ADCs

UCB Plans $5 Billion Manufacturing Investment to Boost Biologics Capacity

Landmark Study Links Newborn Gut Microbiome to Childhood Respiratory Health

Landmark Study Links Newborn Gut Microbiome to Childhood Respiratory Health

AstraZeneca Signs $5.3bn Deal for AI-Driven Research in China
Proteins, Antibodies & ADCs

AstraZeneca Signs $5.3bn Deal for AI-Driven Research in China

MIT and Recursion Go Public With Their AI model, Boltz-2, to Boost Drug Discovery
Proteins, Antibodies & ADCs

MIT and Recursion Go Public With Their AI model, Boltz-2, to Boost Drug Discovery

Adding IL-12 to mRNA Vaccines Enhances T Cell Response to Infection, Study Finds
Vaccines

Adding IL-12 to mRNA Vaccines Enhances T Cell Response to Infection, Study Finds

AZ Reduce Early-Stage Gastric Cancer Progression, Recurrence, and Death in Phase III Trial
Proteins, Antibodies & ADCs

AZ Reduce Early-Stage Gastric Cancer Progression, Recurrence, and Death in Phase III Trial

Preclinical Research Targets Newborn Stem Cells for In Vivo Gene Therapy
Cell & Gene

Preclinical Research Targets Newborn Stem Cells for In Vivo Gene Therapy

Positive Results for Kite’s CAR-T, Yescarta in R/R LBCL Outpatients
Cell & Gene

Positive Results for Kite’s CAR-T, Yescarta in R/R LBCL Outpatients

Infant Given Personalised Gene Therapy for Rare, Incurable Disease
Cell & Gene

Infant Given Personalised Gene Therapy for Rare, Incurable Disease

HAYA Therapeutics Raises $65M for its Dark Genome Therapy
Oligonucleotides

HAYA Therapeutics Raises $65M for its Dark Genome Therapy

Novo Nordisk CEO Lars Fruergaard Jørgensen Steps Down After Eight Years of Leadership
Peptides

Novo Nordisk CEO Lars Fruergaard Jørgensen Steps Down After Eight Years of Leadership

Brain Mapping Technology Uncovers Neural Pathways in Extraordinary Detail

Brain Mapping Technology Uncovers Neural Pathways in Extraordinary Detail

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.